Last week, we reported that the Scandinavian Journal of Immunology had noted that a 2002 paper by Silvia Bulfone-Paus and colleagues had been retracted, but hadn’t yet published the retraction notice. A commenter tipped us off this week that the notice is out:
Retraction: Enhanced Inhibition of Tumour Growth and Metastasis, and Induction of Antitumour Immunity by IL-2-IgG2b Fusion Protein The following article from Scandinavian Journal of Immunology, ‘Enhanced Inhibition of Tumour Growth and Metastasis, and Induction of Antitumour Immunity by IL-2-IgG2b Fusion Protein’ by Budagian V, Nanni P, Lollini PL, Musiani P, Di Carlo E, Bulanova E, Paus R,
Bulfone-Paus S, published online on 29 April 2002 in Wiley Online Library (http://www.onlinelibrary. wiley.com), has been retracted by agreement between the corresponding ⁄ senior author, the journal Editor in Chief, Roland Jonsson and Blackwell Publishing, Ltd.
The retraction has been agreed due to a finding of scientific misconduct within the laboratory where the experiments took place, and was brought to our attention by the scientific community.
The original paper has been cited three times, according to the Thomson Scientific Web of Knowledge.
On the one hand, the notice gives far less detail than the others in this case so far, which describe particular images that were manipulated. On the other, it doesn’t claim that the data have been reproduced, which several of them, including one in the EMBO Journal, do.
Journals have accepted 12 retractions of papers by Bulfone-Paus and colleagues. This is the fifth available notice.